The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment. (Q51466997)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2007
edit
Language Label Description Also known as
English
The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment.
scientific article published in August 2007

    Statements

    The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit